Progress in clinical treatment of low-grade gliomas
10.3969/j.issn.1002-0152.2024.05.011
- VernacularTitle:低级别胶质瘤临床治疗进展
- Author:
Penghang GUO
1
;
Dong XIE
;
Quantang ZHAO
;
Yu GAO
;
Yaqiang NAN
;
Guanghong ZENG
;
Jie ZHOU
Author Information
1. 中国人民解放军联勤保障部队第九四〇医院神经外科 甘肃中医药大学第一临床学院(兰州730000)
- Keywords:
Low-grade gliomas(LGG);
Surgery;
Radiotherapy;
Chemotherapy;
Targeted therapy;
Immune therapy
- From:
Chinese Journal of Nervous and Mental Diseases
2024;50(5):310-314
- CountryChina
- Language:Chinese
-
Abstract:
low-grade glioma(LGG)is a slow-growing primary brain tumor originating from glial cells.The overall prognosis of LGG is good but incurable.The vast majority of LGG will have relapses,and some even progress to high-grade glioma(HGG).The treatment of LGG is still controversial.The current treatment includes surgical resection,radiation therapy(RT),chemical treatment(CT),targeting and immunotherapy,but its effectiveness and safety need further clinical exploration.This article describes the treatment of LGG,including surgery,radiotherapy,chemotherapy,targeting and immunotherapy,in order to develop an individualized treatment plan and provide theoretical strategies for maximizing the survival time of patients and improving the prognosis of patients.
